Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 2
NET tracers first widened, then closed imaging access gap
By
Will Morton
Ga-68 DOTATATE/DOTATOC captured 33.8% market share in its 2017 debut and reached 90.9% by 2020.
April 30, 2026
Serac highlights study on 99mTc-maraciclatide for endometriosis care
By
AuntMinnie.com staff writers
Serac Healthcare is highlighting success from a study that evaluated the company's gamma-emitting radiotracer, 99mTc-maraciclatide.
April 30, 2026
Lu-177 PSMA-SPECT/CT predicts survival in mCRPC
By
Will Morton
Lu-177 PSMA-617 SPECT/CT total tumor volume complete response at six weeks associated with overall survival.
April 29, 2026
PET improves treatment planning for pituitary tumors
By
Will Morton
Ga-68 DOTATATE PET altered radiation treatment volumes by nearly 20% compared with MRI alone.
April 28, 2026
PharmaLogic opens PET radiopharmaceutical facility in Atlanta
By
AuntMinnie.com staff writers
PharmaLogic Holdings has opened a PET radiopharmaceutical manufacturing facility in Atlanta.
April 28, 2026
C-Ray Therapeutics wins FDA active status for Cu-64 drug master file
By
AuntMinnie.com staff writers
C-Ray Therapeutics has received active status from the FDA for its Type II Drug Master File for Cu-64 chloride for radiolabeling.
April 28, 2026
Plus Therapeutics beefs up manufacturing with SpectronRx
By
AuntMinnie.com staff writers
Partnership supports 2026 radiopharmaceutical supply goal.
April 27, 2026
ChatGPT matches nuclear medicine experts on FDG-PET/CT scans
By
Will Morton
Models excelled on cases with well-defined metabolic patterns, such as in typical cases of Alzheimer's disease, yet were less accurate on complex cases.
April 24, 2026
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
By
AuntMinnie.com staff writers
TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.
April 22, 2026
Ionetix raises $30M to scale radioisotope production
By
AuntMinnie.com staff writers
The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.
April 21, 2026
FAPI-PET superior to FDG-PET in liver cancer
By
Will Morton
The finding is from a prospective head-to-head comparison among 59 patients with suspicious lesions.
April 20, 2026
MITA PET Group rebrands, expands scope to theranostics
By
AuntMinnie.com staff writers
The new name reflects an expanded focus beyond diagnostic radiopharmaceuticals to include theranostics.
April 20, 2026
Previous Page
Page 2 of 626
Next Page
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
